Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
148 studies found for:    Open Studies | Central Nervous System Infections
Show Display Options
Rank Status Study
1 Unknown  Long Term Outcomes of EV71 CNS Infection
Condition: Central Nervous System Infection
Intervention:
2 Unknown  Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)
Condition: Central Nervous System Infection
Intervention:
3 Recruiting Singapore Neurologic Infections Program
Condition: Central Nervous System Infections
Intervention:
4 Not yet recruiting Vietnam Cryptococcal Retention in Care Study
Conditions: Meningitis, Cryptococcal;   Central Nervous System Fungal Infections;   Central Nervous System Infections;   Meningitis, Fungal
Intervention: Drug: Fluconazole
5 Recruiting National Study on Listeriosis and Listeria
Conditions: Listeriosis;   Pregnancy Complications;   Infectious;   Central Nervous System Infections;   Septicemia;   Sepsis; Listeria Monocytogenes
Intervention:
6 Recruiting Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Conditions: Brain Injury;   Central Nervous System Degenerative Disorder;   Central Nervous System Infectious Disorder;   Central Nervous System Vascular Malformation;   Hemorrhagic Cerebrovascular Accident;   Ischemic Cerebrovascular Accident;   Primary Brain Neoplasm;   Brain Cancer;   Brain Tumors
Interventions: Drug: Ferumoxytol;   Other: Tissue Analysis;   Procedure: Magnetic Resonance Imaging
7 Recruiting Daptomycin in Pediatric Patients With Bacterial Meningitis
Condition: Meningitis
Intervention: Drug: Daptomycin
8 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
9 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
10 Not yet recruiting Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection
Conditions: Liver Injury;   Hepatitis B Virus Infection History
Intervention: Other: HBV infection history
11 Not yet recruiting Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
Conditions: HTLV-I Infections;   Tropical Spastic Paraparesis
Intervention: Drug: "Raltegravir" and "Zidovudine"
12 Recruiting Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
13 Recruiting Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
14 Recruiting Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
15 Recruiting Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
16 Recruiting Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free);   Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)
17 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
18 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
19 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
20 Recruiting Study on Early Lyme Neuroborreliosis
Condition: Nervous System Lyme Borreliosis
Intervention: Drug: ceftriaxone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years